Piramal Pharma Limited — Important, 19-02-2025: Updates

Piramal Pharma Limited has submitted a Postal Ballot Notice seeking shareholder approval for the appointment of Ms. Nathalie Leitch as a Non-Executive, Non-Independent Director. Ms. Leitch brings over 20 years of experience in the pharmaceuticals sector, including leadership roles at major firms like Teva Pharmaceuticals and Fresenius Kabi. She has expertise in commercial management, pipeline oversight for generic products, and strategic partnerships. The remote e-voting process for this resolution will start on February 20 and end on March 21, with the results to be published on the company's website and disclosed to stock exchanges. This initiative indicates a focus on bolstering corporate governance and leveraging Ms. Leitch's substantial industry experience to drive growth. Investors should stay alert to the outcomes of this ballot as it could influence the company's strategic direction.